Singapore, Singapore

Chia-Yi Liu

This inventor holds 1 USPTO granted patent. Top assignee: Hummingbird Bioscience Holdings Pte. Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chia-Yi Liu. Retrieved from https://idiyas.com/inventor/chia-yi-liu-0hhoitxk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chia-Yi Liu: Innovator in Antigen-Binding Molecules

Introduction

Chia-Yi Liu is a prominent inventor based in Singapore, known for his contributions to the field of biotechnology. He has made significant strides in the development of antigen-binding molecules, which have important applications in medical research and treatment.

Latest Patents

Chia-Yi Liu holds a patent for "BCMA/TACI Antigen-Binding Molecules." This innovative work showcases his expertise in creating molecules that can bind to specific antigens, potentially leading to advancements in therapeutic strategies.

Career Highlights

Currently, Chia-Yi Liu is associated with Hummingbird Bioscience Holdings Pte. Ltd., where he continues to push the boundaries of scientific research. His work at this company emphasizes the importance of collaboration and innovation in the biotechnology sector.

Collaborations

Chia-Yi Liu has worked alongside notable colleagues such as Fabien Decaillot and Jerome Douglas Boyd-Kirkup. Their combined efforts contribute to the advancement of research and development in their field.

Conclusion

Chia-Yi Liu's contributions to the field of antigen-binding molecules highlight his role as an influential inventor in biotechnology. His work not only reflects his expertise but also the collaborative spirit of innovation in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…